Lars Farde

7PUBLICATIONS
27CO-AUTHORS
Sensor technology (incl. chemical aspects)PharmacogenomicsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Molecular targetsSensory systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2025
Radiolabeling and Preliminary In Vivo Evaluation of the Candidate CCR2 Targeting PET Radioligand [11C]AZD2423.

Kenneth Dahl, Peter Johnström, Miklós Tóth

|Nov 11, 2021
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis.

Pontus Plavén-Sigray, Pauliina Ikonen Victorsson, Alexander Santillo

|Sep 22, 2021
No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis.

Maria Lee, Helena Fatouros-Bergman, Pontus Plavén-Sigray

|Oct 08, 2020
Preclinical Comparison of the Blood-brain barrier Permeability of Osimertinib with Other EGFR TKIs.

Nicola Colclough, Kan Chen, Peter Johnström

|Aug 28, 2020
Serotonin transporter availability in adults with autism-a positron emission tomography study.

Max Andersson, Ämma Tangen, Lars Farde

|Oct 05, 2018
GABAA receptor availability is not altered in adults with autism spectrum disorder or in mouse models.

Jamie Horder, Max Andersson, Maria A Mendez

Pageof 2